Loading candles…
Balaxi Pharmaceuticals Ltd is an intellectual property rights-based pharmaceutical company operating within the pharmaceutical industry. It produces, stocks, sells, and supplies branded medicines, generic medicines, and branded generics. The company employs an asset-light business model with a focus on frontier markets in Africa, Central America, and Latin America, including countries such as Angola, Guatemala, and the Dominican Republic. Balaxi Pharmaceuticals manages the entire process from product registration and sourcing to last-mile delivery. It leverages a deep supply chain and distribution network to provide affordable healthcare solutions across these regions. No information is available regarding its incorporation year, founders, key management, subsidiaries, or stock exchange listings.
| Audited Results - Q4 & FY25 | To consider and approve the audited financial results (Standalone & Consolidated) for the fourth quarter and financial year March 31, 2025 and other business… | 30 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.